Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 156
- −3 vs. Q1 2023
- Portfolio value
- $7.01B
- +$119.3M (+1.7%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VRTXVertex Pharmaceuticals Inc | Stock | 1,097,166 | $386.1M | 5.5% | −48,529−4.2% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 9,380,300 | $384.9M | 5.5% | −131,600−1.4% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 923,284 | $359.8M | 5.1% | +36,356+4.1% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 842,224 | $288.0M | 4.1% | −126,562−13.1% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 2,612,800 | $246.4M | 3.5% | −5000.0% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 3,201,800 | $202.7M | 2.9% | −66,200−2.0% | Reduced | History |
| MRNAModerna, Inc. | Stock | 1,525,059 | $185.3M | 2.6% | −26,647−1.7% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,646,501 | $179.5M | 2.6% | −4150.0% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 899,650 | $170.9M | 2.4% | +16,400+1.9% | Added | History |
| INCYIncyte Corp | COM | 2,640,765 | $164.4M | 2.3% | −199,735−7.0% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 3,114,375 | $146.4M | 2.1% | +24,375+0.8% | Added | History |
| SYKStryker Corp | Stock | 476,946 | $145.5M | 2.1% | −7,828−1.6% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 2,661,452 | $144.0M | 2.1% | −778,127−22.6% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 4,746,000 | $127.0M | 1.8% | −1,9000.0% | Reduced | History |
| MDTMedtronic plc | Stock | 1,410,492 | $124.3M | 1.8% | +181,257+14.7% | Added | History |
| INSPInspire Medical Systems, Inc. | COM | 357,020 | $115.9M | 1.7% | −20,048−5.3% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,013,500 | $113.7M | 1.6% | 00.0% | Unchanged | History |
| AXNXAxonics, Inc. | COM | 2,223,418 | $112.2M | 1.6% | +311,557+16.3% | Added | History |
| EVHEvolent Health, Inc. | CL A | 3,448,322 | $104.5M | 1.5% | +1,257,175+57.4% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 210,127 | $101.0M | 1.4% | +15,316+7.9% | Added | History |
| PACBPacific Biosciences of California, Inc. | COM | 7,542,829 | $100.3M | 1.4% | +516,723+7.4% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 1,038,092 | $97.9M | 1.4% | −2,577−0.2% | Reduced | History |
| DXCMDexcom Inc | COM | 761,716 | $97.9M | 1.4% | +6,637+0.9% | Added | History |
| EXASExact Sciences Corp | COM | 1,006,772 | $94.5M | 1.3% | −218,270−17.8% | Reduced | History |
| PODDInsulet Corp | Stock | 323,594 | $93.3M | 1.3% | 00.0% | Unchanged | History |
| BDXBecton Dickinson & Co | Stock | 337,723 | $89.2M | 1.3% | −10,320−3.0% | Reduced | History |
| PENPenumbra Inc | COM | 234,220 | $80.6M | 1.1% | −3,952−1.7% | Reduced | History |
| SWAVShockwave Medical, Inc. | COM | 270,526 | $77.2M | 1.1% | −10,850−3.9% | Reduced | History |
| OPCHOption Care Health, Inc. | COM NEW | 2,287,623 | $74.3M | 1.1% | −154,562−6.3% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 3,300,911 | $69.6M | 1.0% | +7,809+0.2% | Added | History |
| OMOutset Medical, Inc. | COM | 3,125,886 | $68.4M | 1.0% | +219,127+7.5% | Added | History |
| CRLCharles River Laboratories International, Inc. | COM | 314,513 | $66.1M | 0.9% | +12,067+4.0% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,800,000 | $61.1M | 0.9% | 00.0% | Unchanged | History |
| ACCDAccolade, Inc. | COM | 4,521,059 | $60.9M | 0.9% | +479,258+11.9% | Added | History |
| ALGNAlign Technology Inc | COM | 171,140 | $60.5M | 0.9% | 00.0% | Unchanged | History |
| IDXXIDEXX Laboratories Inc | COM | 114,441 | $57.5M | 0.8% | +3,513+3.2% | Added | History |
| HUMHumana Inc | Stock | 127,373 | $57.0M | 0.8% | +58,803+85.8% | Added | History |
| VEEVVeeva Systems Inc | Stock | 271,046 | $53.6M | 0.8% | +8,061+3.1% | Added | History |
| ARVNArvinas, Inc. | COM | 2,127,000 | $52.8M | 0.8% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 4,170,800 | $52.4M | 0.7% | −1,8000.0% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 612,613 | $51.4M | 0.7% | −16,871−2.7% | Reduced | History |
| MGNXMacrogenics Inc | COM | 9,609,913 | $51.4M | 0.7% | 00.0% | Unchanged | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 2,092,934 | $51.4M | 0.7% | +299,171+16.7% | Added | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 134,533 | $51.0M | 0.7% | +20,794+18.3% | Added | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 899,300 | $50.5M | 0.7% | −500−0.1% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 96,101 | $50.1M | 0.7% | +9,768+11.3% | Added | History |
| MOHMolina Healthcare, Inc. | COM | 164,338 | $49.5M | 0.7% | +21,729+15.2% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 160,515 | $48.7M | 0.7% | −143,271−47.2% | Reduced | History |
| EXELExelixis, Inc. | COM | 2,534,000 | $48.4M | 0.7% | −75,000−2.9% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 518,495 | $47.2M | 0.7% | −590,887−53.3% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 102,453 | $45.5M | 0.6% | +9,483+10.2% | Added | History |
| LLYEli Lilly & Co | Stock | 95,155 | $44.6M | 0.6% | +84,391+784.0% | Added | History |
| DHRDanaher Corp | Stock | 183,709 | $44.1M | 0.6% | −153,682−45.6% | Reduced | History |
| SILKSilk Road Medical Inc | COM | 1,356,763 | $44.1M | 0.6% | +287,024+26.8% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 284,835 | $41.5M | 0.6% | +19,565+7.4% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 574,363 | $41.3M | 0.6% | +133,013+30.1% | Added | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 8,135,839 | $41.1M | 0.6% | +2,740,000+50.8% | Added | History |
| GMEDGlobus Medical Inc | Stock | 647,645 | $38.6M | 0.6% | 00.0% | Unchanged | History |
| ATRCAtriCure, Inc. | COM | 748,613 | $37.0M | 0.5% | +101,391+15.7% | Added | History |
| IQVIQVIA Holdings Inc. | Stock | 162,120 | $36.4M | 0.5% | −10,358−6.0% | Reduced | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 288,779 | $35.8M | 0.5% | −281,078−49.3% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 306,694 | $35.4M | 0.5% | +299,619+4,234.9% | Added | History |
| COOCooper Companies, Inc. | COM NEW | 86,567 | $33.2M | 0.5% | +5,254+6.5% | Added | History |
| CDNACareDx, Inc. | COM | 3,716,477 | $31.6M | 0.5% | +277,386+8.1% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 360,604 | $31.3M | 0.4% | +312,159+644.4% | Added | History |
| PRVAPrivia Health Group, Inc. | COM | 1,122,644 | $29.3M | 0.4% | +120,000+12.0% | Added | History |
| PRCTPROCEPT BioRobotics Corp | COM | 741,517 | $26.2M | 0.4% | 00.0% | Unchanged | History |
| HOLXHologic Inc | COM | 290,136 | $23.5M | 0.3% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 4,855,779 | $23.1M | 0.3% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 200,220 | $22.9M | 0.3% | −446,394−69.0% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 695,421 | $22.2M | 0.3% | 00.0% | Unchanged | History |
| HCMHUTCHMED (China) Ltd | SPONSORED ADS | 1,805,583 | $21.7M | 0.3% | −21,387−1.2% | Reduced | History |
| OMCLOmnicell, Inc. | COM | 293,345 | $21.6M | 0.3% | −170,022−36.7% | Reduced | History |
| RMDResmed Inc | COM | 98,275 | $21.5M | 0.3% | 00.0% | Unchanged | History |
| AMEDAmedisys Inc | COM | 234,318 | $21.4M | 0.3% | −308,298−56.8% | Reduced | History |
| EPIXESSA Pharma Inc. | COM NEW | 7,898,583 | $21.3M | 0.3% | 00.0% | Unchanged | History |
| GBIOGeneration Bio Co. | COM | 3,620,280 | $19.9M | 0.3% | 00.0% | Unchanged | History |
| PHRPhreesia, Inc. | COM | 638,653 | $19.8M | 0.3% | 00.0% | Unchanged | History |
| CNCCentene Corp | Stock | 292,527 | $19.7M | 0.3% | −256,814−46.7% | Reduced | History |
| SUPNSupernus Pharmaceuticals, Inc. | COM | 650,256 | $19.5M | 0.3% | +527,375+429.2% | Added | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 275,754 | $19.0M | 0.3% | −231,500−45.6% | Reduced | History |
| TXG10x Genomics, Inc. | CL A COM | 324,746 | $18.1M | 0.3% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 5,219,425 | $17.2M | 0.2% | +919,806+21.4% | Added | History |
| WVEWave Life Sciences, Inc. | SHS | 4,494,458 | $16.4M | 0.2% | 00.0% | Unchanged | History |
| SRRKScholar Rock Holding Corp | COM | 2,140,025 | $16.1M | 0.2% | 00.0% | Unchanged | History |
| ILMNIllumina, Inc. | COM | 84,026 | $15.8M | 0.2% | −15,231−15.3% | Reduced | History |
| CSTLCastle Biosciences Inc | COM | 1,124,043 | $15.4M | 0.2% | +175,165+18.5% | Added | History |
| DOCSDoximity, Inc. | CL A | 448,579 | $15.3M | 0.2% | 00.0% | Unchanged | History |
| CICigna Group | Stock | 50,399 | $14.1M | 0.2% | −3,077−5.8% | Reduced | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 572,315 | $12.1M | 0.2% | +309,632+117.9% | Added | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 16,327 | $11.7M | 0.2% | +1,011+6.6% | Added | History |
| PNTPOINT Biopharma Global Inc. | COM | 1,256,197 | $11.4M | 0.2% | +1,256,197 | New | History |
| NTRANatera, Inc. | COM | 232,775 | $11.3M | 0.2% | 00.0% | Unchanged | History |
| TDOCTeladoc Health, Inc. | COM | 392,264 | $9.93M | 0.1% | −40,457−9.3% | Reduced | History |
| BAXBaxter International Inc | Stock | 213,434 | $9.72M | 0.1% | −60,180−22.0% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 112,650 | $8.68M | 0.1% | +12,294+12.3% | Added | History |
| BIIBBiogen Inc. | COM | 25,598 | $7.29M | 0.1% | +894+3.6% | Added | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 85,600 | $6.13M | 0.1% | +14,000+19.6% | Added | History |
| AMGNAmgen Inc | Stock | 27,310 | $6.06M | 0.1% | −11,057−28.8% | Reduced | History |
| ESPREsperion Therapeutics, Inc. | COM | 4,208,264 | $5.85M | 0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2023 (12)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| PFEPfizer Inc | Stock | 740,695 | $30.2M | 0.4% | History |
| HALOHalozyme Therapeutics, Inc. | COM | 742,400 | $28.4M | 0.4% | History |
| BNTXBioNTech SE | SPONSORED ADS | 196,480 | $24.5M | 0.4% | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 598,046 | $19.5M | 0.3% | History |
| ZLABZai Lab Ltd | ADR | 159,400 | $5.30M | 0.1% | History |
| ISEEIVERIC bio, Inc. | COM | 52,900 | $1.29M | <0.1% | History |
| CAHCardinal Health Inc | Stock | 10,600 | $800.3K | <0.1% | History |
| XNCRXencor Inc | COM | 25,400 | $708.4K | <0.1% | History |
| CYVNYOpthea Ltd | SPONSORED ADS | 47,000 | $186.1K | <0.1% | History |
| IPGPIpg Photonics Corp | COM | 1,050 | $129.5K | <0.1% | History |
| BMYBristol Myers Squibb Co | Stock | 1,496 | $103.7K | <0.1% | History |
| HSICHenry Schein Inc | COM | 1,043 | $85.0K | <0.1% | History |